Application of the dosimetric model described by Humm to target 131I monoclonal antibodies to leukaemic cells in the cerebrospinal fluid.
Papanastassiou
V
V
Pizer
B L
BL
Kemshead
J T
JT
D006801:Humans; D007938:Leukemia / Q000134:cerebrospinal fluid / Q000473:pathology / Q000532:radiotherapy*; D008954:Models, Biological; D016499:Radioimmunotherapy; D011879:Radiotherapy Dosage